1. Sandeep Kumar Bansal, Jainendra Jain, Ravi Dutt Sharma, “Anticancer cationic cyclic peptides and method of synthesis thereof” Indian Patent published on 31/12/2021(Patent No. 202011026516A)
2. Kurmi RK, Sinha R, Agrawal A, Bansal S.K., Lavhale PM, Srivastava S. 2025. Antiepileptic Impact of Isoindole-1,3-diones Compounds: An Updated Review on Diversified Synthesis and Modes of Action. Curr Bioact Compd, 21(8), 1-13 DOI: 10.2174/0115734072306875241118105536
3. Arora PK, Kumar S, Bansal S.K., Virmani T. 2024. In silico Exploration of Quinazolinone-incorporated-chalcones as EGFR inhibitors (T790M mutated) to Combat Lung Cancer. Orient J Chem, Vol. 40(5): 1382-1393. https://dx.doi.org/10.13005/ojc/400521
4. Chauhan H, Bansal SK, Agrawal A. 2023. Molecular Docking Studies of Benzimidazole Analogues as Novel Anti-Inflammatory Agents. Int J Pharm Edu Res. 5(2):7-10. DOI https://doi.org/10.37021/ijper.v5i2.02
5. P. K. Arora, S. Kumar, S. K. Bansal “Synthesis, In Vitro Cytotoxicity And In Silico Investigations of Quinazolinone Integrated Chalcones: As Novel Potential Dual Targeting Anticancer Agents to Treat Lung Cancer And Colorectal Cancer” Rasayan Journal of chemistry. 2023, 16(3), 1104-1115. DOI: http://doi.org/10.31788/RJC.2023.1638343
6. P. K. Arora, S. Kumar, S. K. Bansal, P.C. Sharma, “Synthesis, in-Vitro Cytotoxicity, Molecular Docking of Few Quinazolinone Incorporated Naphthyl Chalcones: As Potential Dual Targeting Anticancer Agents to Treat Lung Cancer and Colorectal Cancer” Oriental Journal of Chemistry, 2023, 39(2), 231-245. http://dx.doi.org/10.13005/ojc/390202.
7. H. Singh, R. Sinha, S. K. Bansal, R. Kaushik, K. K. Verma, “In-Silico Docking Studies of Carbonic Anhydrase Inhibitors in the Management of Neuropathic Pain” Journal of Applied Pharmaceutical Sciences and Research”, 2022, 5(4), 17. DOI https://doi.org/10.31069/japsr.v5i4.03
8. P. K. Arora, S. Kumar, S. K. Bansal “Docking –based virtual screening of Lipinski compliant 2-arylquinazolin-4-one derivatives: a momentum to the discovery of novel EGFR inhibitors” International Journal of Pharmaceutical Sciences and Research, 2021, 12 (3), 1699-1712. DOI https://doi.org/10.13040/IJPSR.0975-8232.12(3).1699-12
9. S.K. Bansal, B.N. Sinha, R.L. Khosa “Anthraquinones: A scaffold hope to novel γ-amino butyric acid aminotransferase inhibitors” Journal of Applied Pharmaceutical Sciences and Research, 2018, 1(2), 10-15. DOI https://doi.org/10.31069/japsr.v1i2.13062
10. Jainendra Jain, S.K. Bansal (Guest Editors for special issue) “Advances and Research in Heterocyclics: an Impetus to Central Nervous System Agents” Central Nervous System Agents in Medicinal Chemistry, 2017. DOI https://benthamscience.com/journal-files/special-issue-details/CNSAMC-SII20150313-1.pdf
11. Deepti Pandey, S.K. Bansal, R.D. Sharma, A.K.Ganguly “Virtual Screening of Glycine Analogs: A Structural Insight to NMDA and GABA-AT Receptor” Drug Discovery & Development, 2014, 1(1), 17-26. DOI https://www.hkbpublications.com/DDD?journalcode=3ac7bdc6-1557-4bb1-839f-acfb814ff364&articlecode=0775097c-4e77-4855-8853-f5a2fddc6a4&show=articledetail
12. Jainendra Jain, S.K. Bansal, P. Chaudhary, R. Sinha, U. Tripathi, M.Malhotra. “In silico pharmacophore validation of anticonvulsant activity of (E) (±)-3-menthone derivatives” Bulletin of Pharmaceutical Research, 2013, 3(3), 146-156. DOI https://journal.appconnect.in/wpcontent/uploads/2013/10/FirstPagePreviewBPR084.pdf
13. S.K. Bansal, B.N. Sinha, R.L. Khosa. “γ-amino butyric acid analogs as novel potent GABA-AT inhibitors: Molecular docking, synthesis and biological evaluation” Medicinal Chemistry Research, 2013, 22(1), 134-146. DOI https://doi.org/10.1007/s00044-012-0023-0
14. S.K. Bansal, B.N. Sinha, R.L. Khosa. “Docking based virtual screening of schiff’s bases of GABA- a prospective to novel GABA-AT inhibitors” Medicinal Chemistry Research, 2012, 21(10), 3063-3072. DOI https://doi.org/10.1007/s00044-011-9843-6
15. S.K. Bansal, B.N. Sinha, R.L. Khosa, A.J. Olson. “Novel GABA-AT inhibitors: QSAR & docking based virtual screening of phenyl substituted β-phenyl ethylidene hydrazine analogs” Medicinal Chemistry Research, 2011, 20(9), 1482-1489. DOI https://doi.org/10.1007/s00044-010-9390-6
16. S.K. Bansal, B.N. Sinha, R.L. Khosa. “QSAR & docking based computational chemistry approach to novel GABA-AT inhibitors: kNN-MFA based 3DQSAR model for phenyl substituted analogs of β -phenyl ethylidene hydrazine” Medicinal Chemistry Research, 2011, 20(5), 549-553. DOI https://doi.org/10.1007/s00044-010-9350-1
17. S.K. Bansal, B.N. Sinha, R.L. Khosa, A.J. Olson. “Novel GABA-AT inhibitors: QSAR & docking based virtual screening of phenyl substituted β-phenyl ethylidene hydrazine analogs” Medicinal Chemistry Research, 2010, 19, 114 DOI https://doi.org/10.1007/s00044-010-9293-6
18. N. Kumar, J.S. Jain, R. Sinha, V.K. Garg, S.K. Bansal. “Evaluation of some novel chalcone derivatives for antimicrobial & anti-inflammatory” Der Pharmacia Lettre, 2009, 1(1), 169-176. DOI https://www.scholarsresearchlibrary.com/articles/evaluation-of-some-novel-chalcone-derivatives- for-antimicrobial-and-antiinflammatory-activity.pdf
19. K.K. Jha, A. Samad, Y. Kumar, R.L. Khosa, J.S. Jain, S.K. Bansal. “3D QSAR studies of 1,3,4-oxadiazole derivatives as antimicrobial agents” Iranian Journal of Pharmaceutical Research, 2009, 8(3), 163-167. DOI https://doi.org/10.22037/IJPR.2010.806
20. B.N. Sinha, S.K. Bansal, A.K. Pattnaik. “Phytochemical & antimicrobial activity of extracts, fractions, & betulin, 7-methyl juglone obtained from Diospyros paniculata” Journal of Natural Remedies, 2009, 9(1), 99-102. DOI: https://doi.org/10.18311/jnr/2009/228(http://informaticsjournals.in/index.php/jnr/article/view/228/22 8)
21. B.N. Sinha, S.K. Bansal. “A review of phytochemical & biological studies of Diospyros species used in folklore medicine of Jharkhand” Journal of Natural Remedies, 2008, 8(1), 11-17. DOI: https://doi.org/10.18311/jnr/2008/289(http://informaticsjournals.in/index.php/jnr/article/view/289/289 )
22. N. Aggarwal, R. Aggarwal, P. Mishra, J.S. Jain, S.K. Bansal, K.K. Jha. “Design and evaluation of semicarbazones & thiosemicarbazones as novel anticonvulsants” Central Nervous System Agents in Medicinal Chemistry, 2008, 8(1), 26-28. DOI : https://doi.org/10.2174/187152408783790596